T-cell differentiation to the TH2-subtype, the isotype switch towards IgE and effects on goblet cell hyperplasia and smooth muscle contractility are prevented by blocking IL-4 and IL-13 simultaneously, which may result in improved asthma outcomes [47, 56, 63]. The gene discussed is IL4; the disease is asthma.